So, that’s why Kezar Life Sciences, Inc. (KZR) stock peaked in the after-hours session

Kezar Life Sciences, Inc. (Nasdaq: KZR), the stock soared 17.65% to $6.5 in the after-hours session following the biotechnology firm disclosed that it was added to the NASDAQ Biotech Index (Nasdaq: NBI), effective before market opening on Monday 21 December 2020.

The NASDAQ Biotechnology Index is intended to measure stocks’ success traded on the Nasdaq Stock Exchange (Nasdaq), categorized under the Industry Classification Benchmark as either biotechnology or pharmaceutical (ICB). Under an updated capitalization-weighted algorithm, the NASDAQ Biotechnology Index is calculated.

#1 Small-Cap Uranium Stock for Ultra-Fast Gains in 2024

We've uncovered THE ONE small-cap uranium stock that has unearthed a near-surface, high-grade uranium discovery in the Saudi Arabia of Uranium — Canada's prolific Athabasca Basin. Best of all, this small-cap uranium stock is currently flying just below Wall Street's radar… giving you the early-entry opportunity around US$0.30 per share. But that won't last long. Drills are turning right now with results set to be released to the market very, very soon.

Learn all about it in this brand new FREE online report.

NASDAQ Biotechnology Index firms must meet eligibility rules, including minimum market capitalization, estimated daily trading volume and, among other factors, seasoning as a public company. In December, Nasdaq selects constituents once per annum. For more information about the NASDAQ.

Most Popular

Related posts